Detalles de la búsqueda
1.
Persistence of immunity after vaccination with a capsular group B meningococcal vaccine in 3 different toddler schedules.
CMAJ
; 189(41): E1276-E1285, 2017 Oct 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-29038320
2.
Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trial.
Lancet
; 384(9960): 2123-31, 2014 Dec 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-25145775
3.
Persistence of specific bactericidal antibodies at 5 years of age after vaccination against serogroup B meningococcus in infancy and at 40 months.
CMAJ
; 187(7): E215-E223, 2015 Apr 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-25802309
4.
Immunogenicity and safety of an investigational multicomponent, recombinant, meningococcal serogroup B vaccine (4CMenB) administered concomitantly with routine infant and child vaccinations: results of two randomised trials.
Lancet
; 381(9869): 825-35, 2013 Mar 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-23324563
5.
Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b/3 randomised, observer-blind, placebo-controlled study.
Lancet
; 379(9816): 617-24, 2012 Feb 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-22260988
6.
Persistence of bactericidal antibodies following early infant vaccination with a serogroup B meningococcal vaccine and immunogenicity of a preschool booster dose.
CMAJ
; 185(15): E715-24, 2013 Oct 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-24062178
7.
Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial.
JAMA
; 307(6): 573-82, 2012 Feb 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-22318278
8.
The first use of an investigational multicomponent meningococcal serogroup B vaccine (4CMenB) in humans.
Hum Vaccin
; 7(6): 646-53, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21904120
9.
Early clinical experience with a candidate meningococcal B recombinant vaccine (rMenB) in healthy adults.
Hum Vaccin
; 7(7): 781-91, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21734467
10.
Immunogenicity and Safety of Investigational MenABCWY Vaccine and of 4CMenB and MenACWY Vaccines Administered Concomitantly or Alone: a Phase 2 Randomized Study of Adolescents and Young Adults.
mSphere
; 6(6): e0055321, 2021 12 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-34787449
11.
Immunogenicity and safety of different schedules of the meningococcal ABCWY vaccine, with assessment of long-term antibody persistence and booster responses - results from two phase 2b randomized trials in adolescents.
Hum Vaccin Immunother
; 17(11): 4689-4700, 2021 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34582323
12.
Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy.
Clin Infect Dis
; 51(10): 1127-37, 2010 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20954968
13.
Does vaccination with 4CMenB convey protection against meningococcal serogroup B strains not predicted to be covered by MATS? A study of the UK clonal complex cc269.
Hum Vaccin Immunother
; 16(4): 945-948, 2020 04 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31770063
14.
Persistence of the immune response after 4CMenB vaccination, and the response to an additional booster dose in infants, children, adolescents, and young adults.
Hum Vaccin Immunother
; 15(12): 2940-2951, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31246520
15.
Immunogenicity of the pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) administered concomitantly with the meningococcal serogroup B (4CMenB) vaccine in infants: A post-hoc analysis in a phase 3b, randomised, controlled trial.
Vaccine
; 37(35): 4858-4863, 2019 08 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-31327652
16.
Evaluation of strain coverage of the multicomponent meningococcal serogroup B vaccine (4CMenB) administered in infants according to different immunisation schedules.
Hum Vaccin Immunother
; 15(3): 725-731, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30352000
17.
Antibody persistence and booster response in adolescents and young adults 4 and 7.5 years after immunization with 4CMenB vaccine.
Vaccine
; 37(9): 1209-1218, 2019 02 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-30691980
18.
Breadth of coverage against a panel of 110 invasive disease isolates, immunogenicity and safety for 2 and 3 doses of an investigational MenABCWY vaccine in US adolescents - Results from a randomized, controlled, observer-blind phase II study.
Vaccine
; 36(35): 5309-5317, 2018 08 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-30061029
19.
Immune Responses to Booster Vaccination With Meningococcal ABCWY Vaccine After Primary Vaccination With Either Investigational or Licensed Vaccines: A Phase 2 Randomized Study.
Pediatr Infect Dis J
; 37(5): 475-482, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29329168
20.
Safety and immunogenicity of a meningococcal B recombinant vaccine when administered with routine vaccines to healthy infants in Taiwan: A phase 3, open-label, randomized study.
Hum Vaccin Immunother
; 14(5): 1075-1083, 2018 05 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29337653